---
title: "Zacks Small-Cap Research Highlights Ainos' Smell AI Commercialization | AIMD Stock News"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286785872.md"
description: "Zacks Small-Cap Research Highlights Ainos' Smell AI Commercialization | AIMD Stock News"
datetime: "2026-05-18T06:15:32.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286785872.md)
  - [en](https://longbridge.com/en/news/286785872.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286785872.md)
---

# Zacks Small-Cap Research Highlights Ainos' Smell AI Commercialization | AIMD Stock News

Zacks Small-Cap Research Highlights Ainos' Smell AI Commercialization | AIMD Stock News

### Related Stocks

- [AIMD.US](https://longbridge.com/en/quote/AIMD.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [AIMDW.US](https://longbridge.com/en/quote/AIMDW.US.md)

## Related News & Research

- [Lantern Pharma raises capital, plans AI platform spinoff](https://longbridge.com/en/news/286480334.md)
- [Analyst Reiterates Buy on Corbus, Maintains $38 Price Target on CRB-701 Oncology Potential](https://longbridge.com/en/news/286284525.md)
- [Dyadic International Q1 net loss narrows](https://longbridge.com/en/news/286311192.md)
- [Alkermes reports encouraging data from Phase III study of Lumryz](https://longbridge.com/en/news/286349759.md)
- [Precigen Q1 revenue beats estimates on PAPZIMEOS launch](https://longbridge.com/en/news/286311056.md)